2017年美国心脏病学会和美国心脏协会血压分类在妊娠后半期与不良妊娠结局相关性的系统综述
该系统综述纳入12项研究,评估2017年美国心脏病学会和美国心脏协会血压分类与不良妊娠结局的关系。结果显示,与正常血压相比,较高的血压类别与不良结局相关,其中「2期高血压」(血压≥140/90 mm Hg)关联最强;无任何血压类别可作为排除不良结局的诊断试验,仅「2期高血压」对先兆子痫等可作为「纳入诊断」试验。
要点
- 妊娠20周后,与正常血压相比,较高的血压类别与不良妊娠结局相关。
- 「2期高血压」(血压≥140/90 mm Hg)与不良结局的关联最强。
- 仅「2期高血压」对先兆子痫等可作为「纳入诊断」试验,阳性似然比≥5.0。
核心结论
- 从妊娠20周起,收缩压140 mm Hg和舒张压90 mm Hg的血压阈值有助于识别不良妊娠结局风险增加的女性,与测量血压的具体孕龄无关。
- 降低妊娠20周后异常血压的阈值不会帮助临床医生识别孕产妇或围产期风险增高的女性。
- 没有任何美国心脏病学会或美国心脏协会血压阈值能提供 reassurance 表明女性不太可能发生不良结局。
研究设计与样本
- 系统综述,检索2017年至2021年电子数据库,纳入12项记录妊娠20周及以上血压的研究。
- 采用荟萃分析探讨血压阈值与不良结局关联强度,并计算考虑孕龄的诊断试验特性。
主要发现
- 与正常血压相比,较高的血压类别与不良结局持续相关,关联强度在「2期高血压」(血压≥140/90 mm Hg)时最大。
- 在妊娠20周后任何时间或特定孕龄组(20-27、28-32或33-36周)报告峰值血压时,结果相似。
- 所有血压类别的阴性似然比均≥0.2,无任何类别可作为不良结局的「排除诊断」试验。
- 仅「2期高血压」可作为「纳入诊断」试验,对妊娠20周后最大血压预测先兆子痫及任何孕龄组血压预测先兆子痫、子痫、卒中、孕产妇死亡和死产,阳性似然比≥5.0。
关键数值与推荐
- 血压分类:正常(收缩压<120 mm Hg且舒张压<80 mm Hg)、血压升高(收缩压120-129 mm Hg且舒张压<80 mm Hg)、1期高血压(收缩压130-139 mm Hg和/或舒张压80-89 mm Hg)、2期高血压(收缩压≥140 mm Hg和/或舒张压≥90 mm Hg)。
- 研究纳入标准:记录妊娠20周及以上血压的研究。
临床怎么用
- 从妊娠20周起,收缩压140 mm Hg和舒张压90 mm Hg的阈值有助于识别不良妊娠结局风险增加的女性。
- 降低妊娠20周后异常血压的阈值不会帮助临床医生识别风险增高的女性。
- 没有任何美国心脏病学会或美国心脏协会血压阈值能提供 reassurance 表明女性不太可能发生不良结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A relationship between the 2017 American College of Cardiology and American Heart Association blood pressure thresholds and adverse pregnancy outcomes has been reported, but few studies have explored the diagnostic test properties of these cutoffs when used within pregnancy. DATA SOURCES: Electronic databases were searched (2017-2021) for measurements of blood pressure in pregnancy at >20 weeks, classified according to the 2017 American College of Cardiology and American Heart Association criteria, and their relationship with pregnancy outcomes. Blood pressure was categorized as "normal" (systolic blood pressure of <120 mm Hg and diastolic blood pressure of <80 mm Hg), "elevated blood pressure" (systolic blood pressure of 120-129 mm Hg and diastolic blood pressure of <80 mm Hg), "stage 1 hypertension" (systolic blood pressure of 130-139 mm Hg and/or diastolic blood pressure of 80-89 mm Hg), and "stage 2 hypertension" (systolic blood pressure of ≥140 mm Hg and/or diastolic blood pressure of ≥90 mm Hg). STUDY ELIGIBILITY CRITERIA: Studies recording blood pressure at or above 20 weeks gestation were included. METHODS: Meta-analyses were used to investigate the strength of the association between blood pressure cutoffs and adverse outcomes, and the diagnostic test properties were calculated accounting for gestation. RESULTS: There were 12 included studies. The American College of Cardiology or American Heart Association blood pressure categories were determined from peak blood pressures at any point from 20 weeks of gestation and at specific gestational ages (20-27, 28-32, or 33-36 weeks of gestation), as available. A higher (vs normal) blood pressure category was consistently associated with adverse outcomes. The strength of association between blood pressure categories and adverse outcomes was the greatest with "stage 2 hypertension" (blood pressure of ≥140/90 mm Hg). The results were similar when peak blood pressure was reported either at any time from 20 weeks of gestation or within gestational age groups (as above). No blood pressure category was useful as a diagnostic "rule-out test" for adverse outcomes, as all negative likelihood ratios were ≥0.2. Only "stage 2 hypertension" was useful as a "rule in-test," with positive likelihood ratios of ≥5.0, for maximum blood pressure at >20 weeks of gestation for preeclampsia and blood pressure within any gestational age groups for preeclampsia, eclampsia, stroke, maternal death, and stillbirth. CONCLUSION: From 20 weeks of gestation, blood pressure thresholds of 140 mm Hg (systolic) and 90 mm Hg (diastolic) were useful in identifying women at increased risk of adverse pregnancy outcomes, irrespective of the specific gestational age at blood pressure measurement. Lowering the blood pressure threshold for abnormal blood pressure at >20 weeks of gestation would not assist clinicians in identifying women at heightened maternal or perinatal risk. No American College of Cardiology or American Heart Association blood pressure threshold can provide reassurance that women are unlikely to develop adverse outcomes.
引用
- Slade LJ, Wilson M, Mistry HD, et al. The 2017 American College of Cardiology and American Heart Association blood pressure categories in the second half of pregnancy-a systematic review of their association with adverse pregnancy outcomes. Am J Obstet Gynecol. 2023. PMID: 36657559. doi:10.1016/j.ajog.2023.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。